Proprietary technology and a vision for the future of antibody therapeutics make Alder the ideal partner for leading pharmaceutical and biotechnology companies. Since our inception, we have actively pursued strategic alliances with commercial and academic partners who share our goal of reducing the time and cost of developing superior antibodies for a range of unmet medical needs. Today we are actively looking for strategic partners to help us develop our pipeline of therapeutic products in the areas of cancer, rheumatoid arthritis, and anemia. To see if Alder is a good fit for you, or to learn about our proprietary technologies and therapeutics in more detail, please contact us.
Collaborative Partners:
 |
 |
